The Enterprise Value as of September 2024 (TTM) for Acorda Therapeutics, Inc. (ACOR) is 187.38M

According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 187.38M. This represents a change of 3.67% compared to the average of 180.75M of the last 4 quarters.

Acorda Therapeutics, Inc. (ACOR) Historical Enterprise Value (quarterly & annually)

How has ACOR Enterprise Value performed in the past?

The mean historical Enterprise Value of Acorda Therapeutics, Inc. over the last ten years is 766.27M. The current 187.38M Enterprise Value has changed 2.35% with respect to the historical average. Over the past ten years (40 quarters), ACOR's Enterprise Value was at its highest in in the December 2015 quarter at 2.03B. The Enterprise Value was at its lowest in in the December 2022 quarter at 154.12M.

Acorda Therapeutics, Inc. (ACOR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acorda Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acorda Therapeutics, Inc. (ACOR) Average Enterprise Value

How has ACOR Enterprise Value performed in the past?

The current Enterprise Value of Acorda Therapeutics, Inc. (ACOR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acorda Therapeutics, Inc. (ACOR) Enterprise Value vs. Peers

How is ACOR’s Enterprise Value compared to its peers?

Acorda Therapeutics, Inc.’s Enterprise Value is less than Taisho Pharmaceutical Holdings Co., Ltd. (384.67B), less than Shionogi & Co., Ltd. (1.55T), greater than Vivesto AB (13.02M), less than Pacira BioSciences, Inc. (1.02B), greater than Sunshine Biopharma, Inc. (-7489992.00), greater than Lucy Scientific Discovery Inc. (2.06M), greater than Biofrontera Inc. (3.88M), greater than Jupiter Wellness, Inc. (45.30M), greater than Shuttle Pharmaceuticals Holdings, Inc. (4.20M), less than Lifecore Biomedical, Inc. (279.48M), greater than Journey Medical Corporation (112.48M), greater than Akanda Corp. (6.21M), greater than China Pharma Holdings, Inc. (6.75M), greater than Universe Pharmaceuticals INC (11.58M), greater than Sonoma Pharmaceuticals, Inc. (1.79M), greater than Petros Pharmaceuticals, Inc. (3.82M), greater than Evoke Pharma, Inc. (-712315.00), greater than Cumberland Pharmaceuticals Inc. (22.56M), greater than Agile Therapeutics, Inc. (7.87M), greater than PainReform Ltd. (-1679947.00),

Build a custom stock screener for Acorda Therapeutics, Inc. (ACOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acorda Therapeutics, Inc. (ACOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.